Related Experiment Video
Updated: Jun 17, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
[Analysis of acute myocardial infarction one month after stent implantation]
Guang-yuan Song1, Li-jian Gao, Yue-jin Yang
1Center of Coronary Heart Disease, Cardiovascular Institute & Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China.
Insights
ST-elevated acute myocardial infarction (STEAMI) one month after percutaneous coronary intervention (PCI) is more often caused by new lesions than stent thrombosis. Diabetes and drug-eluting stents increase late thrombosis risk.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- ST-elevated acute myocardial infarction (STEAMI) following percutaneous coronary intervention (PCI) requires understanding of underlying causes.
- Distinguishing between new-lesion myocardial infarction and in-stent thrombosis is crucial for patient management.
Purpose of the Study:
- To investigate the etiological factors of STEAMI occurring within one month after a prior successful PCI.
- To identify patient and procedural characteristics associated with different causes of early post-PCI STEAMI.
Main Methods:
- A cohort of 192 patients (40-79 years) with successful prior PCI who presented with STEAMI requiring primary PCI was analyzed.
- Lesions causing STEAMI were categorized as new-lesion or late stent thrombosis based on angiographic location relative to previous stents.
- Patient demographics, previous angiographic findings, stent types, and procedural outcomes were recorded.
Main Results:
- New-lesion myocardial infarction was the predominant cause (75%) of early STEAMI, while late stent thrombosis accounted for 25%.
- Patients with late stent thrombosis had a significantly longer interval from previous PCI compared to those with new-lesion MI.
- Diabetes mellitus and the use of drug-eluting stents were significantly associated with an increased risk of late stent thrombosis.
Conclusions:
- Early STEAMI post-PCI is more frequently attributed to progression of previously insignificant lesions rather than late stent thrombosis.
- Diabetes mellitus and drug-eluting stents are risk factors for late stent thrombosis, suggesting a need for intensified antiplatelet therapy in these patients.
Objective:
To study the possible causes of ST-elevated acute myocardial infarction (STEAMI) occurring one month after percutaneous coronary intervention (PCI).
Methods:
One hundred and ninety two patients aged from 40 - 79 years who had a successful previous PCI and also received primary PCI due to STEAMI in this hospitalization were included in this study. The AMI-related lesions and previous angiographic findings such as the number of lesions, the degree of the stenosis, the type of stents and the acute results of last PCI, etc. were recorded in detail. If the AMI-related lesion was localized in-stents or at the edge of stents (distance from the edge < or = 5 mm), it was defined as late thrombosis, otherwise it was regarded as an AMI induced by new-lesion.
Results:
New lesions, as the cause of STEAMI, were found in 144 cases (Group A, 75%), and late thrombosis in 48 patients (Group B, 25%). There was a significant difference in the average time from previous PCI to AMI (30.1 +/- 12.4 vs. 20.3 +/- 11.9 months) between the two groups. Diabetes mellitus (DM) and drug-eluting stents (DES) utilization were associated with markedly higher morbidity of late thrombosis in adjusted logistic regression analysis [hazard ratio (HR) 3.387, 95% CI 1.053 - 10.898 and HR 5.311, 95%CI 1.066 - 26.464].
Conclusions:
STEAMI occurred 1 month after PCI are more likely to be developed from previous insignificant lesions than from late thrombosis in stents. Moreover, DM and DES are associated with a high incidence of late thrombosis, which may indicate that intensive antiplatelet therapy should be considered in diabetic patients receiving PCI.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome IV: Interprofessional Care
